Cancer Drug

Natural Cancer Supplement: Cell Forte with IP-6 and Inositol by Enzymatic Therapy

Wed, 13 Feb 2008 03:46:35 +0100

Cell Forte with IP-6 is a unique combination of inositol and inositol hexaphosphate (IP-6). Together, inositol and IP-6 create a remarkable increase in natural killer cell activity and enhances natural cellular defenses. Both inositol and IP-6 are found naturally in the cells of the body. However, studies show that by supplementing with Cell Forte, the cells become stronger.

Drug may ward off prostate cancer Medication cuts risk by 25%

Drug may ward off prostate cancer Medication cuts risk by 25%, could prevent 300,000 tumors in men older than 55, researchers say By MARILYNN MARCHIONE mmarchione@journalsentinel.com, Journal Sentinel Wednesday, June 25, 2003 For the first time, a drug has been shown to prevent prostate cancer, ...

Cancer drugs: weighing the risks and benefits.

Few deliberations have greater bearing on human health than when the Food and Drug Administration weighs the risks and benefits of drugs designed to treat life-threatening diseases, such as cancer. FDA physicians who specialize in treating cancer , chemists, statisticians, ...

Presented By

Drug resistance: malaria-cancer similarity

Drug resistance: Malaria-cancer similarity Researchers at the Walter Reed ArmyInstitute of Research in Washington, D.C., report experimental evidence that malaria-causing parasites may be using the same defense against antimalaria drugs as cancer cells do against certain anticancer drugs. If both ...

BREAST CANCER DRUG HAS SERIOUS SIDE EFFECTS BUT IT'S SHOWN TO PREVENT DISEASE.

A drug found to prevent breast cancer in half of high-risk women also causes serious side effects, researchers cautioned yesterday, leaving women with a complex decision about the best course to protect their health. ``The results tell us that breast cancer can be prevented, but there is no simple ...

How Well Tested Are the New Cancer Drugs

With a certain amount of regularity a new cancer drug makes headlines, generating an enormous amount of hope, as well as pressure to make the product swiftly available. In time, we usually learn that the drug's benefit is much more modest than originally portrayed in the media, and soon oncologists ...

Cancer drug that's saved 20,000 lives; BOFFINS HAIL SUCCESS STORY.

A GROUNDBREAKING breast cancer drug, which costs the same as a headache pill, was said yesterday to have saved the lives of 20,000 women over the past 10 years. And medical boffins are sure the drug - first discovered in Wales - will cut future death rates by up to 30 per cent. Scientists for the ...

Callisto Announces Licensing of a New Class of Cancer Drugs With a Novel Mechanism of Action, Showing Potent Antitumor Activity.

Drug Class Developed at The University of Texas M. D. Anderson Cancer Center NEW YORK, Jan. 26 /PRNewswire-FirstCall/ - Callisto Pharmaceuticals, Inc. , a developer of new drug treatments in the fight against cancer and other major health threats, has announced that it signed ...

"Cancer Drug Delivery Report launched today" says Pharma Business Daily.

M2 PRESSWIRE-15 October 2001-Visiongain: Cancer Drug Delivery Report launched today says Pharma Business Daily 1994-2001 M2 COMMUNICATIONS LTD RDATE:15102001 $26.4 billion was invested in the drug industry in 2000. With drug delivery systems emerging as a sector of the industry experiencing ...

Drug May Prevent Breast Cancer; Doctors to Release Raloxifene Data

A new drug may profoundly reduce women's odds of getting breast cancer, according to eagerly awaited data to be released by researchers today. The drug, raloxifene, recently gained Food and Drug Administration approval for the prevention of the bone-thinning disease osteoporosis in post-menopausal ...

A Hospital's Conflict Of Interest; Patients Weren't Told Of Stake in Cancer Drug

One of the nation's largest cancer centers enrolled 195 people in tests of an experimental drug without informing them that the institution's president held a financial interest in the product that stood to earn him millions. The tests at M.D. Anderson Cancer Center in Houston involved Erbitux, the ...